Owens & Minor Inc. (OMI, Financials) shares plummeted 35.2% on Monday, closing at $9.23, after the company said it is moving forward with its planned acquisition of Rotech Healthcare Holdings, announcing that it has begun raising funds to support the deal. The company expects to finalize the purchase in the first half of 2025.
Owens & Minor projects a net loss between $288 million and $311 million but sales for the fourth quarter between $2.67 billion and $2.70 billion. A major component of the loss is a $310 million goodwill impairment charge linked to its Apria subsidiary, which the firm ascribed to market conditionsincluding a declining stock price and increasing interest rates.
With a net loss ranging from $355 million to $378 million, full-year income for 2024 is anticipated to be between $10.67 billion and $10.70 billion. Notwithstanding the losses, the business highlighted strong success in its Patient Direct division, which witnessed consistent mid-single-digit growth. Over the previous year, Owens & Minor also lowered overall debt by more than $240 million.
Pesicka said he still sees great demand for the company's goods and services and is hopeful about its long-term plan.
On Feb. 28, Owens & Minor will provide its complete fourth-quarter and yearly financial figures.
This article first appeared on GuruFocus.免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。